Lv3
330 积分 2021-06-15 加入
Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications
5小时前
待确认
Antibody-Based Biotherapeutics in Inflammatory Diseases
1天前
已完结
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus
1天前
已完结
Clinical Pharmacokinetics of the Anti-Interleukin-20 Monoclonal Antibody NNC0109-0012 in Healthy Volunteers and Patients with Psoriasis or Rheumatoid Arthritis
1天前
已完结
Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis
1天前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
5天前
已完结
Safety and Pharmacokinetics of Subcutaneous Blinatumomab (SC blinatumomab) for the Treatment of Adults with Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL); Results from a Phase 1b Study
7天前
已关闭
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
22天前
已完结
Immunogenicity and Efficacy of Personalized Adjuvant mRNA Cancer Vaccines
22天前
已完结
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
25天前
已完结
皖公网安备34019202002308
